Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Duncan, Christine  [Clear All Filters]
2024
Takahashi T, Watkins B, Bratrude B, Neuberg D, Hebert K, Betz K, Yu A, Choi SW, Davis J, Duncan C, et al. The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities. Transplant Cell Ther. 2024.
2023
Lauer A, Speroni SL, Choi M, Da X, Duncan C, McCarthy S, Krishnan V, Lusk CA, Rohde D, Hansen MBo, et al. Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy. Nat Commun. 2023;14(1):1900.
Schoettler ML, Lehmann LElaine, Kao P-C, Chen N, Jodele S, Chonat S, Williams KM, London WB, Duncan C, Dandoy CE. Pediatric Transplant Associated Thrombotic Microangiopathy Healthcare Utilization and Implications of Eculizumab Therapy. Blood Adv. 2023.
Harrison DJ, Daly KP, Gauvreau K, Epstein SF, Walsh ML, Colan S, Duncan C, Lehmann L, Chen MHui. Survivors of Pediatric Hematopoietic Stem Cell Transplant Exhibit Progressive Diastolic Dysfunction Over Years of Follow-up. Transplant Cell Ther. 2023.
2021
Qayed M, Watkins B, Gillespie S, Bratrude B, Betz KM, Choi SWon, Davis JH, Duncan C, Giller RH, Grimley M, et al. Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation. Blood Adv. 2021.
Marsh RA, Hebert K, Kim S, Dvorak CC, Aquino V, K Baker S, Chellapandian D, Saldana BDavila, Duncan C, Eckrich MJ, et al. A Comparison of Hematopoietic Cell Transplant Conditioning Regimens for Hemophagocytic Lymphohistiocytosis Disorders. J Allergy Clin Immunol. 2021.
Brodigan K, Kapadia M, A Frazier L, Laufer MR, Yu R, Weil BR, Ginsburg ES, Duncan C, Lehmann L. Safety of surgical fertility preservation procedures in children prior to Hematopoietic Stem Cell Transplant. Transplant Cell Ther. 2021.
2020
Arnold SD, Brazauskas R, He N, Li Y, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, et al. The impact of donor type on outcomes and cost of allogeneic hematopoietic cell transplant for pediatric leukemia: a merged CIBMTR and PHIS analysis: Pediatric acute leukemia transplant risks and utilization. Biol Blood Marrow Transplant. 2020.
2019
Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, et al. Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. Biol Blood Marrow Transplant. 2019.
2015
Gertz S, Duncan C, Moffet J, Mahadeo K, Cheifetz I, Tamburro R, Rowan C. 414: RESPIRATORY PATHOGEN EFFECT ON INTUBATED PEDIATRIC PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANT. Crit Care Med. 2015;43(12 Suppl 1):105.